GH1 and acromegaly: In acromegaly, both first-generation somatostatin analogues, octreotide and lanreotide, exert their pharmacological effects mainly by binding to SSTR2 and to a lesser extent to SSTR5 [3], which are both expressed by most growth hormone (GH)-secreting pituitary adenomas [4].